Gibraltar Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Gibraltar Capital Management, Inc.

$216 Million
Q3 2024

A detailed history of Gibraltar Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gibraltar Capital Management, Inc. holds 115,268 shares of BMY stock, worth $6.66 Million. This represents 2.76% of its overall portfolio holdings.

Number of Shares

115,268

Previous 112,171 2.76%

Holding current value

$6.66 Million

Previous $4.66 Million 28.06%

% of portfolio

2.76%

Previous 2.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$39.66 - $51.75 $122,827 - $160,269	3,097 Added 2.76%	115,268 $5.97 Million
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $84,484 - $111,226	2,099 Added 1.91%	112,171 $4.66 Million
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $1.57 Million - $1.78 Million	32,691 Added 42.25%	110,072 $5.97 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $766,856 - $915,071	-15,818 Reduced 16.97%	77,381 $3.97 Million
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $122,379 - $136,839	2,114 Added 2.32%	93,199 $5.41 Million
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $107,542 - $119,409	1,688 Added 1.89%	91,085 $5.82 Million
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $75,895 - $86,082	1,155 Added 1.31%	89,397 $6.2 Million
Q4 2022 Jan 13, 2023	BUY	$68.48 - $81.09 $67,795 - $80,279	990 Added 1.13%	88,242 $0
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $534 - $316,119	-4,114 Reduced 4.5%	87,252 $6.2 Million
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $984,146 - $1.08 Million	-13,552 Reduced 12.92%	91,366 $7.04 Million
Q1 2022 Apr 11, 2022	BUY	$61.48 - $73.72 $45,433 - $54,479	739 Added 0.71%	104,918 $7.66 Million
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $213,447 - $248,829	-3,980 Reduced 3.68%	104,179 $6.5 Million
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $205,970 - $241,268	3,481 Added 3.33%	108,159 $6.4 Million
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $385,823 - $420,161	6,232 Added 6.33%	104,678 $6.98 Million
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $837,050 - $941,434	14,106 Added 16.73%	98,446 $6.2 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $50,349 - $57,054	872 Added 1.04%	84,340 $5.23 Million
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $297,717 - $329,909	-5,184 Reduced 5.85%	83,468 $5.03 Million
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $54,545 - $63,769	-995 Reduced 1.11%	88,652 $5.21 Million
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $94,192 - $136,882	-2,030 Reduced 2.21%	89,647 $5 Million
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $548,986 - $716,103	11,156 Added 13.85%	91,677 $5.89 Million
Q3 2019 Oct 09, 2019	BUY	$42.77 - $50.71 $220,051 - $260,902	5,145 Added 6.83%	80,521 $4.08 Million
Q2 2019 Jul 17, 2019	BUY	$44.62 - $49.34 $37,971 - $41,988	851 Added 1.14%	75,376 $3.42 Million
Q1 2019 Apr 11, 2019	BUY	$45.12 - $53.8 $3.36 Million - $4.01 Million	74,525 New	74,525 $3.56 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gibraltar Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gibraltar Capital Management, Inc. with notifications on news.

Account

Gibraltar Capital Management, Inc. Bristol Myers Squibb CO Transaction History